Although PCSK9 plasma levels did not appear to have a role as a circulating prognostic biomarker, at least in the context of early breast neoplastic events, its role in breast cancer progression in other settings should be explored, including the consideration of PCSK9 breast tissue expression as well as its role in predicting the severity of the pathology. The gene discussed is PCSK9; the disease is breast carcinoma.